Rifampin and rifabutin resistance mechanism in Helicobacter pylori

169Citations
Citations of this article
66Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Eighty-one clinical isolates of Helicobacter pylori showed no resistance to rifampin (MIC range, 0.032 to 2 μg/ml; MIC at which 50% of isolates are inhibited [MIC50], 0.25 μg/ml). The MIC50 of rifabutin was 0.008 μg/ml (n = 16). All resistant laboratory mutants of H. pylori ATCC 43504 showed amino acid exchanges in codons 524 to 545 or codon 585 of the rpoB gene, corresponding to the gene sequences from Mycobacterium tuberculosis and Escherichia coli.

Cite

CITATION STYLE

APA

Heep, M., Beck, D., Bayerdörffer, E., & Lehn, N. (1999). Rifampin and rifabutin resistance mechanism in Helicobacter pylori. Antimicrobial Agents and Chemotherapy, 43(6), 1497–1499. https://doi.org/10.1128/aac.43.6.1497

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free